{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:17:36Z","timestamp":1793377056044,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008781","name":"Pomorski Uniwersytet Medyczny W Szczecinie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.pnpbp.2019.109679","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T11:54:52Z","timestamp":1561550092000},"page":"109679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Evaluation of hyperhomocysteinemia prevalence and its influence on the selected cognitive functions in patients with schizophrenia"],"prefix":"10.1016","volume":"95","author":[{"given":"Beata","family":"Trze\u015bniowska-Druka\u0142a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Kalinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Safranow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"K\u0142oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u0142a\u017cej","family":"Misiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Samochowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pnpbp.2019.109679_bb0005","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jn\/129.5.919","article-title":"Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement","volume":"129","author":"Bailey","year":"1999","journal-title":"J. Nutr."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.5604\/17322693.1102340","article-title":"Hyperhomocysteinemia in patients with cardiovascular disease","volume":"68","author":"Baszczuk","year":"2014","journal-title":"Postepy Hig. Med. Dosw. (Online)."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/schbul\/18.1.43","article-title":"Cognitive rehabilitation for schizophrenia: is it possible? Is it necessary?","volume":"18","author":"Bellack","year":"1992","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2008.01.009","article-title":"No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients","volume":"101","author":"Bromberg","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0025","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/JGP.0b013e318209ddf1","article-title":"Brain biochemical correlates of the plasma homocysteine level: a proton magnetic resonance spectroscopy study in the elderly subjects","volume":"19","author":"Chen","year":"2011","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2019.109679_bb0030","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/schbul\/sbl029","article-title":"The functional significance of social cognition in schizophrenia: a review","volume":"32","author":"Couture","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awg006","article-title":"Homocysteine and brain atrophy on MRI of non-demented elderly","volume":"26","author":"den Heijer","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2019.109679_bb0040","first-page":"513","article-title":"Serum total homocysteine, folate and vitamin B12 levels and their correlation with antipsychotic drug doses in adult male patients with chronic schizophrenia","volume":"56","author":"Eren","year":"2010","journal-title":"Clin. Lab."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0045","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3233\/JAD-2011-110752","article-title":"Homocysteine, vitamin B12 and folic acid levels in Alzheimer's disease, mild cognitive impairment and healthy elderly: baseline characteristics in subjects of the Australian imaging biomarker lifestyle study","volume":"27","author":"Faux","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10072-011-0645-x","article-title":"Cognitive and neurochemical alterations in hyperhomocysteinemic rat","volume":"33","author":"Gao","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0140-6736(90)91942-4","article-title":"Enhancement of recovery from psychiatric illness by methylfolate","volume":"336","author":"Godfrey","year":"1990","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109679_bb0060","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1176\/appi.ajp.161.9.1705","article-title":"Folate, homocysteine, and negative symptoms in schizophrenia","volume":"161","author":"Goff","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109679_bb0065","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jnr.10416","article-title":"Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage","volume":"70","author":"Ho","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2796.2011.02484.x","article-title":"Associations between serum homocysteine. Holotranscobalamin, folate and cognition in the elderly: a longitudinal study","volume":"271","author":"Hooshmand","year":"2012","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.psychres.2009.01.013","article-title":"Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism","volume":"175","author":"Kale","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0080","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4161\/epi.24621","article-title":"Plasma total homocysteine is associated with DNA methylation in patients with schizophrenia","volume":"8","author":"Kinoshita","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.pnpbp.2019.109679_bb0085","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1176\/appi.ajp.159.10.1790","article-title":"Elevated homocysteine levels in young male patients with schizophrenia","volume":"159","author":"Levine","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109679_bb0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biopsych.2005.10.009","article-title":"Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia","volume":"60","author":"Levine","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2019.109679_bb0095","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.encep.2010.12.004","article-title":"Hyperhomocysteinemia and schizophrenia: case control study","volume":"37","author":"Mabrouk","year":"2011","journal-title":"Encephale."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00213-011-2481-3","article-title":"Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement: a randomized controlled trial","volume":"220","author":"Macpherson","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2019.109679_bb0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11011-014-9567-7","article-title":"Elevated homocysteine level in first-episode schizophrenia patients - the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse","volume":"29","author":"Misiak","year":"2014","journal-title":"Metab. Brain Dis."},{"issue":"238","key":"10.1016\/j.pnpbp.2019.109679_bb0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.psychres.2016.01.077","article-title":"Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism","volume":"30","author":"Misiak","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnbeh.2014.00343","article-title":"Homocysteine levels in schizophrenia and affective disorders - focus on cognition","volume":"8","author":"Moustafa","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2019.109679_bb0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.mp.4001746","article-title":"Homocysteine. Methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis","volume":"11","author":"Muntjewerff","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109679_bb0125","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1017\/S1041610211000779","article-title":"Plasma homocysteine and cognitive decline in older hypertensive subjects","volume":"23","author":"Narayan","year":"2011","journal-title":"Int. Psychogeriatr."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.109679_bb0130","first-page":"156","article-title":"Homocysteina jako czynnik ryzyka chor\u00f3b cywilizacyjnych; w jakich przypadkach konieczne jest jej oznaczanie?","volume":"5","author":"Naruszewicz","year":"2008","journal-title":"Choroby Serca i Naczy\u0144."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0135","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/schbul\/sbt154","article-title":"Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia","volume":"40","author":"Nishi","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0140","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/ana.20645","article-title":"Plasma total homocysteine and memory in the elderly: the Hordaland homocysteine study","volume":"58","author":"Nurk","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0145","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.pnpbp.2008.09.009","article-title":"Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia","volume":"32","author":"Petronijevi\u0107","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109679_bb0150","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1176\/appi.ajp.160.5.815","article-title":"Implications for the neural basis of social cognition for the study of schizophrenia","volume":"160","author":"Pinkham","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.109679_bb0155","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1460-9568.2010.07434.x","article-title":"Differential effects of short - and long-term hyperhomocysteinaemia on cholinergic neurons. Spatial memory and microbleedings in vivo in rats","volume":"32","author":"Pirchl","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/WNR.0b013e328346bf85","article-title":"Homocysteine effects on brain volumes mapped in 732 elderly individuals","volume":"22","author":"Rajagopalan","year":"2011","journal-title":"Neuroreport."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01271539","article-title":"Homocysteinemia is a common feature of schizophrenia","volume":"100","author":"Regland","year":"1995","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0170","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2013.900","article-title":"Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia","volume":"70","author":"Roffman","year":"2013","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.pnpbp.2019.109679_bb0175","series-title":"Kaplan and Sadock's Comprehensive Textbook of Psychiatry","first-page":"300","author":"Sadock","year":"2015"},{"key":"10.1016\/j.pnpbp.2019.109679_bb0180","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.neurobiolaging.2008.09.009","article-title":"Homocysteine and inflammation: predictors of cognitive decline in older persons?","volume":"31","author":"van den Kommer","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.pnpbp.2019.109679_bb0185","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpsyc.57.9.907","article-title":"Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect","volume":"57","author":"Weickert","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2019.109679_bb0190","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatr."},{"issue":"supl","key":"10.1016\/j.pnpbp.2019.109679_bb0195","first-page":"23","article-title":"Homocysteina i inne czynniki ryzyka choroby niedokrwiennej serca w populacji Polak\u00f3w w \u015bwietle badania NATPOL Plus","volume":"11","author":"Zdrojewski","year":"2005","journal-title":"Czyn Ryzyka."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619300636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619300636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:47:24Z","timestamp":1759520844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584619300636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":39,"alternative-id":["S0278584619300636"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109679","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of hyperhomocysteinemia prevalence and its influence on the selected cognitive functions in patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109679"}}